REGENXBIO
IPOHome Page
REGENXBIO was founded in 2008, is headquartered in Rockville, United States, lists 201–500 employees, and has $100.5M in recorded funding across 2 rounds.
- Headquarters
- Rockville, Maryland
- Employees
- 201–500
- Founded
- 2008
- Business Model
- B2B
- Website
- regenxbio.com
- Total Funding
- $100.5M
- Last Round
- $70.5M Series DMay 2015
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.
About
REGENXBIO is a clinical-stage gene therapy company leveraging its NAV Technology Platform to develop treatments for rare and serious diseases.
Summary
REGENXBIO is a Biotech company based in Rockville, United States, founded in 2008. It lists 201–500 employees. It has raised $100.5M in total across 2 rounds, most recently a $70.5M Series D round in May 2015. Investors include Venrock, FoxKiser and Fidelity Biosciences.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Oct 2015
Sign up to see all 3 events
Funding: Series D. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/regenxbio"><img src="https://indexed.vc/api/badge/company/regenxbio" alt="REGENXBIO on Indexed.vc" width="260" height="76" /></a>